My role in
'academic detailing', visiting General Practitioners with evidence
based information on prescribing in various therapeutic areas
is also a cognitive service role pharmacists are well qualified
and highly regarded and trusted to do.
At present this role is well supported by The National Prescribing
Service both in monetary support and information supply and training.
The service is operated through the Divisions of General Practice
with pharmacists in the main employed to offer it.
This could well be a role for a community pharmacist with a relationship
with a community medical centre.
All such roles in supply of cognitive services involve a change
in engineering of existing practices and thought processes.
To start with a pharmacist must be freed up from the regulatory
requirement of having to be in the pharmacy at all times.
Pharmacies need to be bigger entities with a staff of pharmacists
able to share the load of dispensing and cognitive services in
the community.
We have to be able to go to the clients at their homes, residential
support agencies or in the surgeries. Time has to be devoted to
preparation.
Researching areas of need, analysis of prescribing patterns in
a community, analysis of current evidence based information that
is always developing in the literature and an acute awareness
of the medication issues in the community.
The pharmacist, to do these functions well, needs to be in touch
with all the health agencies in the community including hospitals,
support groups, universities and centres of research.
So not only will a pharmacist need to be free of the dispensing
function there will be a need to also be a part of it.
To achieve a balance and to be remunerated not only for supply
but also adequately for the service of supplying cognitive services
will need to be refined and committed to.
The services should be able to be directly related to cost savings
in Quality Use of Medicines in a community. For example such cost
savings as a lowering in hospital admissions for medication adverse
events, more judicious risk/benefit prescribing from a GP practice
that reduces waste and non compliance while optimising the health
benefits from therapeutics applied where the evidence supports
the benefit.
When the future of pharmacy is discussed now these should be the
items on the agenda.
New technology has and will continue to streamline the supply
function - what is supplied and how, should be our business and
emphasis.
As this is beginning to be recognised so is the dawn rising on
an exciting and evolving profession.
That is what will ensure a future - not who is supplying the goods.
|